What Is Evo 2?

Evo 2 is a large-scale genomic foundation model developed through a groundbreaking collaboration between the Arc Institute, Stanford University, NVIDIA, UC Berkeley, and UC San Francisco (UCSF). The model was trained on 9.3 trillion DNA base pairs drawn from a highly curated genomic atlas spanning all domains of life — bacteria, archaea, and eukaryotes — making it one of the largest biological sequence models ever built.

At its architectural core, Evo 2 is powered by StripedHyena 2, a novel hybrid architecture co-developed with OpenAI co-founder Greg Brockman during his sabbatical, combining attention mechanisms with state-space models to handle extremely long genomic sequences efficiently.

Alongside the model itself, the Arc Institute released Evo Designer — a user-friendly interface that allows researchers and businesses to interact with Evo 2 directly, designing and evaluating genetic sequences without requiring deep machine learning expertise.

Overview

The convergence of genomics and artificial intelligence has reached a defining moment with the arrival of Evo 2. This cutting-edge Genomic AI platform represents a historic leap in bioinformatics, personalized medicine, and life sciences research. Unlike traditional tools, Evo 2 interprets, learns, and evolves to uncover previously undetectable biological markers.

Unlocking Deeper Genetic Intelligence

  • Beyond Sequencing: Evo 2 moves past raw genome reading into contextual understanding, linking genotype to phenotype in clinically meaningful ways.
  • Adaptive Learning: Using reinforcement learning and deep neural networks, the platform continuously improves its insights based on new data and research.

Core Capabilities

Variant Interpretation

Identifies pathogenic mutations and risk profiles with higher accuracy.

Predictive Modeling

Assesses genetic predisposition to diseases and potential therapeutic outcomes.

Multi-Omics Integration

Analyzes genomic, transcriptomic, and proteomic data within a unified framework.

Clinical Decision Support

Assists clinicians by providing treatment suggestions based on specific genetic profiles.

Transformative Use Cases

Personalized Oncology

Matching patients with targeted therapies based on tumor genomics.

Rare Disease Diagnosis

Detecting ultra-rare mutations across large genetic datasets.

Drug Discovery

Accelerating target identification and biomarker discovery through AI simulation.

Population Genomics

Supporting national genome programs with scalable, intelligent analysis.

Conclusion

Evo 2 is more than a technological milestone; it is a paradigm shift in AI-powered biology. By empowering real-time, personalized medical decisions, it serves as a foundational tool for the next era of healthcare where data and intelligent systems converge to revolutionize human health.